日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The association between APOA1 levels and long-term outcomes in H-type hypertension with acute myocardial infarction patients: A retrospective cohort study

APOA1水平与H型高血压合并急性心肌梗死患者长期预后的关系:一项回顾性队列研究

Zhu, Baozhen; Wu, Peng; He, Zefeng; Ma, Juan; Yan, Ning; Ma, Yuru; Yan, Ru; Ma, Tianshui; Ma, Rongbin; Cong, Guangzhi; Jia, Shaobin; Ma, Xueping

The interplay of APOE and APOA1 gene polymorphisms modulates the risk of type 2 diabetes mellitus in an obese population: a case-control study"

APOE 和 APOA1 基因多态性的相互作用调节肥胖人群中 2 型糖尿病的风险:一项病例对照研究

Usama, Nagla; Ahmed, Amr E; Mekheimer, Salma; Elhadidy, Khaled; Farid, Mahmoud

KRT16 and APOA1: key regulators of proliferation and lipid metabolism in non-small cell lung cancer

KRT16 和 APOA1:非小细胞肺癌增殖和脂质代谢的关键调节因子

Yu, MeiE; Zhu, Ling; Wu, YingXiao; Li, MengLing; Wei, QiongYing

APOA1 binding protein promotes lymphatic cell fate and lymphangiogenesis by relieving caveolae-mediated inhibition of VEGFR3 signaling.

APOA1 结合蛋白通过解除 Caveolae 介导的 VEGFR3 信号抑制来促进淋巴细胞命运和淋巴管生成。

Kim Jun-Dae, Chaudhary Surbhi, Chen Weiqing, Astin Jonathan, Crosier Philip S, Yu Pengchun, Cooke John P, Pownall Henry J, Bellen Hugo J, Le Nhat-Tu, Kiss Daniel L, Wang Guangyu, Rockson Stanley G, Chen Hong, Fang Longhou

Increased pro-SFTPB in HDL promotes the pro-inflammatory transition of HDL and represents a sign of poor prognosis in ARDS patients

高密度脂蛋白(HDL)中促SFTPB的增加会促进HDL的促炎转化,并且是急性呼吸窘迫综合征(ARDS)患者预后不良的标志。

Liu Yang #,Zhuo Xu #,Zhenyan Wang,Fangping Ding,Zhipeng Wu,Xiaoqian Shi,Jing Wang,Yingmin Ma,Jiawei Jin

Akkermansia muciniphila Alleviates Olanzapine-Induced Hepatic Steatosis via the Gut Microbiota-IGFBP2/APOA1-Liver Axis.

Akkermansia muciniphila 通过肠道菌群-IGFBP2/APOA1-肝脏轴缓解奥氮平引起的肝脂肪变性。

Wang Jing, Chen Peiru, Deng Yahui, Yu Lixiu, Tu Chuyue, Xu Xiaojin, Fang Xiangming, Li Weiyong

Decreased plasma APOA1 levels are associated with increased severity of placenta accreta spectrum disorders: a nested case-control study

血浆APOA1水平降低与胎盘植入谱系疾病严重程度增加相关:一项嵌套病例对照研究

Zeng, Shuai; Qu, Jiangxue; Jiang, Hai; Shi, Huifeng; Yan, Jie; Zhao, Yangyu; Chen, Lian

Exchangeable APOA1 on HDL inhibits LDL binding to proteoglycans

高密度脂蛋白上的可交换APOA1抑制低密度脂蛋白与蛋白聚糖的结合

Geh, Esmond N; Swertfeger, Debi K; Roscoe, Isabella; Street, Scott E; Bursey, Alexiana; Sexmith, Hannah; Woollett, Laura A; Davidson, W Sean; Shah, Amy Sanghavi

The congenital APOA1 K107del mutation disrupts the lipid-free conformation of monomeric APOA1 and impairs oligomerization

先天性APOA1 K107del突变破坏了单体APOA1的无脂构象,并损害了其寡聚化。

Díaz Ludovico, Ivo; Gonzalez, Marina C; Garda, Horacio A; Vázquez, Romina F; Maté, Sabina; Tricerri, María A; Ramella, Nahuel A; Bedi, Shimpi; Morris, Jamie; Street, Scott E; Geh, Esmond; Clair, Geremy C; Davidson, W Sean; Melchior, John T

APOA1 promotes tumor proliferation and migration and may be a potential pan-cancer biomarker and immunotherapy target

APOA1促进肿瘤增殖和迁移,可能是一种潜在的泛癌生物标志物和免疫治疗靶点。

Xu, Peiyi; Zhang, Qiuyan; Zhai, Jing; Chen, Pu; Deng, Xueting; Miao, Lin; Zhang, Xiuhua